RNA-seq and RT-qPCR analyses revealed three genes (Lars2, Hmcn1, and Vstm2l) that showed specific downregulation in the IH group and confirmed the involvement of the KEAP1-NFE2L2 antioxidant pathway. The gene discussed is LARS2; the disease is isolated hemihyperplasia.